Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin
Open Access
- 6 July 2017
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 17 (2) , 179-185
Abstract
Mutations in breast cancer susceptibility gene 1 (BRCA1) lead to defects in a number of cellular pathways including DNA damage repair and transcriptional regulation, resulting in the elevated genome instability and predisposing to breast and ovarian cancers. We report a novel mutation LRG_292t1:c.4356delA,p.(Ala1453Glnfs*3) in the 12th exon of BRCA1, in the splice site region near the donor site of intron 12. It is a frameshift mutation with the termination codon generated on the third amino acid position from the site of deletion. Human Splice Finder 3.0 and MutationTaster have assessed this variation as disease causing, based on the alteration of splicing, creation of premature stop codon and other potential alterations initiated by nucleotide deletion. Among the most important alterations are frameshift and splice site changes (score of the newly created donor splice site: 0.82). c.4356delA was associated with two ovarian cancer cases in two families of Slavic origin. It was detected by next generation sequencing, and confirmed with Sanger sequencing in both cases. Because of the fact that it changes the reading frame of the protein, novel mutation c.4356delA p.(Ala1453Glnfs*3) in BRCA1 gene might be of clinical significance for hereditary ovarian cancer. Further functional as well as segregation analyses within the families are necessary for appropriate clinical classification of this variant. Since it has been detected in two ovarian cancer patients of Slavic origin, it is worth investigating founder effect of this mutation in Slavic populations.Keywords
This publication has 29 references indexed in Scilit:
- Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joiningOncotarget, 2015
- Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and PreventionScience, 2014
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI: Journal of the National Cancer Institute, 2013
- The occurrence of germline BRCA1 and BRCA2sequence alterations in Slovenian populationBMC Medical Genetics, 2011
- Peutz–Jeghers syndrome: a systematic review and recommendations for managementGut, 2010
- Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicingHuman Mutation, 2006
- Hereditary ovarian cancerHuman Pathology, 2005
- Genomic variants in exons and introns: identifying the splicing spoilersNature Reviews Genetics, 2004
- Ataxia Telangiectasia Mutated (ATM) Kinase and ATM and Rad3 Related Kinase Mediate Phosphorylation of Brca1 at Distinct and Overlapping SitesJournal of Biological Chemistry, 2001
- Familial Ovarian Cancer and Early Ovarian Cancer: Biologic, Pathologic, and Clinical FeaturesInternational Journal of Gynecological Pathology, 2001